Cancer care rarely advances through a single breakthrough.
Meaningful progress in oncology is built through medtech innovation in cancer care across multiple fronts – early detection, treatment modalities, drug delivery, precision medicine, and immune response. Each advance may address a different challenge, but together they reshape how cancer is diagnosed and treated.
World Cancer Day is a good moment to reflect on how this progress really happens.
At Joya Marketing, we work closely with companies tackling cancer from very different angles. What connects them is not one technology or therapeutic area, but a shared focus on advancing care through targeted, practical innovation.
Below are five MedTech companies we are proud to support, each contributing to medtech innovation in cancer care at a different point along the oncology pathway.
How MedTech Innovation in Cancer Care Is Advancing Oncology
Oncology innovation today extends far beyond new drugs alone. Increasingly, progress depends on how technologies work together to improve outcomes while reducing burden on patients and healthcare systems.
Medtech innovation in cancer care is helping enable:
- Earlier and more accurate diagnosis
- Less invasive treatment approaches
- More personalised therapy selection
- Improved drug delivery and treatment consistency
- Longer-lasting and more targeted immune responses
Together, these advances are changing not just how cancer is treated, but how patients experience care.
IceCure Medical – Minimally Invasive Tumor Treatment
IceCure Medical is advancing cryoablation as a minimally invasive alternative to surgery for certain tumors, including breast cancer.
Using controlled freezing to destroy cancerous tissue, cryoablation aims to:
- Reduce recovery time
- Preserve healthy tissue
- Minimise hospital stays and surgical burden
This approach reflects a growing trend in medtech innovation in cancer care toward treatments that are both effective and less disruptive to patients’ lives.
🔗 https://www.icecure-medical.com
Intragel – Innovating Drug Delivery in Cancer Care
Intragel is developing next-generation long-acting injectables designed to enable sustained, localised drug delivery from a single injection.
In the context of cancer care, improved delivery technologies have the potential to:
- Maintain therapeutic drug levels over extended periods
- Reduce systemic exposure and side effects
- Improve treatment consistency and adherence
While often less visible than frontline therapies, delivery platforms play a critical role in medtech innovation in cancer care by making existing treatments more effective and patient-friendly.
JaxBio – Advancing Early Cancer Detection
JaxBio is focused on early cancer detection using epigenetic biomarkers.
Early diagnosis remains one of the most powerful drivers of improved cancer outcomes. Detecting disease upstream can dramatically expand treatment options and increase survival rates.
By applying advanced biomarker science to early detection, JaxBio highlights how diagnostics are becoming a central pillar of medtech innovation in cancer care – shifting focus from late-stage intervention to earlier, more effective action.
CureResponse – Enabling Functional Precision Oncology
CureResponse is advancing functional precision oncology, helping oncologists select therapies based on how an individual patient’s tumor responds in practice.
Rather than relying solely on genetic markers, this approach evaluates real-time tumor behaviour, supporting more informed and personalised treatment decisions.
Precision medicine is a key component of medtech innovation in cancer care, enabling clinicians to move beyond one-size-fits-all approaches toward truly individualised treatment strategies.
Baccine – Expanding Immuno-Oncology Approaches
Baccine is developing therapeutic cancer vaccines designed to stimulate durable immune responses.
As immuno-oncology continues to evolve, therapeutic vaccines offer a promising path toward:
- Long-term disease control
- Reduced risk of recurrence
- Complementing existing cancer therapies
This work reflects how immune-based approaches are becoming an increasingly important dimension of medtech innovation in cancer care.
Progress in Cancer Care Is Built Through Many Innovations
On World Cancer Day, it’s easy to look for a single defining breakthrough.
In reality, progress in oncology is usually built through many focused advances, developed steadily over time, each addressing a specific unmet need. From detection and diagnosis to treatment, delivery, and immune response, medtech innovation in cancer care continues to reshape outcomes step by step.
Often, these advances happen quietly – long before they make headlines – but together, they are transforming how cancer care is delivered.